» Articles » PMID: 25689875

Changes in Stone Composition over Two Decades: Evaluation of over 10,000 Stone Analyses

Overview
Journal Urolithiasis
Publisher Springer
Specialty Urology
Date 2015 Feb 19
PMID 25689875
Citations 18
Authors
Affiliations
Soon will be listed here.
Abstract

To examine the changes in stone composition from 1990 to 2010. A retrospective review was performed of all renal and ureteral stones submitted from the state of Massachusetts to a single laboratory (Laboratory for Stone Research, Newton, MA) for the years 1990 and 2010. Stone composition was determined by infrared spectroscopy and/or polarizing microscopy. A total of 11,099 stones were evaluated (56.7% from 1990, 43.3% from 2010). From 1990 to 2010, the percentage of stones from females (i.e., female/male ratio) increased significantly (29.8% in 1990 to 39.1% in 2010, p < 0.001). Among women, from 1990 to 2010, there was a significant increase in stones which were >50% uric acid (7.6-10.2%, p < 0.005) and a significant decrease in struvite stones (7.8-3.0%, p < 0.001). Among women with calcium stones, the % apatite per stone decreased significantly (20.0 vs. 11.7%, p < 0.001). Among men, there were no changes in stones which were majority uric acid (11.7-10.8%, p = 0.2). Among men with calcium stones, the % apatite per stone increased significantly (9.8 vs. 12.5%, p < 0.001). Males also demonstrated a significant increase in both cystine (0.1-0.6%, p < 0.001) and struvite stones (2.8-3.7%, p = 0.02). The epidemiology of stone disease continues to evolve and appears to vary according to gender. While some of these findings may be related to population changes in body mass index and obesity, the etiology of others remains unclear.

Citing Articles

Lifestyle Factors and the Microbiome in Urolithiasis: A Narrative Review.

Koudonas A, Tsiakaras S, Tzikoulis V, Papaioannou M, de la Rosette J, Anastasiadis A Nutrients. 2025; 17(3).

PMID: 39940323 PMC: 11820711. DOI: 10.3390/nu17030465.


Protein Intake and High Uric Acid Stone Risk.

Montgomery T, Nair H, Phadke M, Morhardt E, Ludvigson A, Motamedinia P Kidney Med. 2024; 6(9):100878.

PMID: 39279882 PMC: 11399574. DOI: 10.1016/j.xkme.2024.100878.


Comprehensive Approaches to Urolithiasis in Renal Transplants: A Narrative Review.

Solano C, Corrales M, Panthier F, Doizi S, Traxer O J Clin Med. 2024; 13(14).

PMID: 39064308 PMC: 11278228. DOI: 10.3390/jcm13144268.


Medical management of urolithiasis: Great efforts and limited progress.

Jahrreiss V, Seitz C, Quhal F Asian J Urol. 2024; 11(2):149-155.

PMID: 38680579 PMC: 11053322. DOI: 10.1016/j.ajur.2023.05.001.


Management of nephrolithiasis after kidney transplantation: a comprehensive review from the European Renal Association CKD-MBD working group.

Kanbay M, Copur S, Bakir C, Hatipoglu A, Sinha S, Haarhaus M Clin Kidney J. 2024; 17(2):sfae023.

PMID: 38410685 PMC: 10896178. DOI: 10.1093/ckj/sfae023.


References
1.
Parks J, Worcester E, Coe F, Evan A, Lingeman J . Clinical implications of abundant calcium phosphate in routinely analyzed kidney stones. Kidney Int. 2004; 66(2):777-85. DOI: 10.1111/j.1523-1755.2004.00803.x. View

2.
Menke A, Rust K, Fradkin J, Cheng Y, Cowie C . Associations between trends in race/ethnicity, aging, and body mass index with diabetes prevalence in the United States: a series of cross-sectional studies. Ann Intern Med. 2014; 161(5):328-35. DOI: 10.7326/M14-0286. View

3.
Scales Jr C, Smith A, Hanley J, Saigal C . Prevalence of kidney stones in the United States. Eur Urol. 2012; 62(1):160-5. PMC: 3362665. DOI: 10.1016/j.eururo.2012.03.052. View

4.
Curhan G . Epidemiology of stone disease. Urol Clin North Am. 2007; 34(3):287-93. PMC: 2693870. DOI: 10.1016/j.ucl.2007.04.003. View

5.
Daudon M, Traxer O, Conort P, Lacour B, Jungers P . Type 2 diabetes increases the risk for uric acid stones. J Am Soc Nephrol. 2006; 17(7):2026-33. DOI: 10.1681/ASN.2006030262. View